Showing results (71-80 of 113) with videos related to
Sort By:
Pageof 12
Journal of Clinical Microbiology|January 13, 2004
Evaluation of the NCCLS M44-P disk diffusion method for determining susceptibilities of 276 clinical isolates of Cryptococcus neoformans to fluconazoleM A Pfaller, S A Messer, L Boyken, et al.Journal of Clinical Microbiology|July 10, 2004
Cross-resistance between fluconazole and ravuconazole and the use of fluconazole as a surrogate marker to predict susceptibility and resistance to ravuconazole among 12,796 clinical isolates of Candida sppM A Pfaller, S A Messer, L Boyken, et al.Journal of Clinical Microbiology|November 23, 2007
In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillanceM A Pfaller, L Boyken, R J Hollis, et al.Journal of Clinical Microbiology|July 3, 1998
International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. The SENTRY Participant GroupM A Pfaller, R N Jones, G V Doern, et al.Infection Control and Hospital Epidemiology|December 1, 1996
A prolonged outbreak of methicillin-resistant Staphylococcus aureus in the burn unit of a tertiary medical centerP A Meier, C D Carter, S E Wallace, et al.Diagnostic Microbiology and Infectious Disease|March 17, 2004
In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance programM A Pfaller, S A Messer, L Boyken, et al.Journal of Clinical Microbiology|November 3, 2006
Use of fluconazole as a surrogate marker to predict susceptibility and resistance to voriconazole among 13,338 clinical isolates of Candida spp. Tested by clinical and laboratory standards institute-recommended broth microdilution methodsM A Pfaller, S A Messer, L Boyken, et al.Journal of Clinical Microbiology|June 20, 2008
In vitro survey of triazole cross-resistance among more than 700 clinical isolates of Aspergillus speciesM A Pfaller, S A Messer, L Boyken, et al.Journal of Clinical Microbiology|July 10, 2004
Further standardization of broth microdilution methodology for in vitro susceptibility testing of caspofungin against Candida species by use of an international collection of more than 3,000 clinical isolatesM A Pfaller, S A Messer, L Boyken, et al.Journal of Clinical Microbiology|August 28, 2009
In vitro susceptibility of clinical isolates of Aspergillus spp. to anidulafungin, caspofungin, and micafungin: a head-to-head comparison using the CLSI M38-A2 broth microdilution methodM A Pfaller, L Boyken, R J Hollis, et al.Pageof 12